ADVAIR HFA*
Manufacturer Details
GLAXO SMITH KLINE INC
Refer Glaxo Smith Kline
Compositions:
Fluticasone propionate 45mcg ,
Salmeterol 21mcg per actuation in canisters with 120 metered inhalations,
Strength
|
Rate
|
Packing Style
|
45mcg + 21mcg
|
0.00
|
in 120 metered inhalations
|
List of Related Indications:
List Of Drugs:
- Fluticasone Propionate/ Salmeterol - Respiratory Inhalant Combinations
Indication Type Description:
Dosages/ Overdosage Etc:
Indication-
Asthma
Dosage-
Asthma-
Fluticasone/Salmeterol -Diskus -
for long term use- twice daily maintenance treatment of asthma in patients 4 years of age and older
Fluticasone/Salmeterol hydrofluoraalkane - HFA -
for long term use - twice daily maintenance treatment of asthma in patients with 12 years of age
and older
Chronic obstructive pulmonary disease COPD - associated with chronic bronchitis DISKUS only-
for the twice daily maintenance treatment of airflow obstruction in patients with COPD associated
with chronic bronchitis